Contact Lens (Mis)Labeling as Misbranding and Overwarning

DSpace/Manakin Repository

Contact Lens (Mis)Labeling as Misbranding and Overwarning

Citable link to this page

. . . . . .

Title: Contact Lens (Mis)Labeling as Misbranding and Overwarning
Author: Delacourt, John T.
Citation: Contact Lens (Mis)Labeling as Misbranding and Overwarning (1996 Third Year Paper)
Full Text & Related Files:
Abstract: One of the most important functions of the Food and Drug Administration (FDA) is the administration of labeling requirements promulgated pursuant to the Federal Food, Drug, and Cosmetic Act (FDCA). This function is especially important in the area of medical devices. Although consumers may use such devices on a routine basis, most lack both the scientific knowledge to adequately inform themselves of the risks of device usage and the resources to keep abreast of developments in the device field. But protecting consumers involves more than merely informing them of risks. The FDA has also sought to restrain its regulatory power in this area in order to provide device manufacturers with the flexibility needed to innovate and to ensure widespread device distribution. Any FDA decision in the device labeling context, therefore, inevitably involves the weighing of these two often contradictory goals.
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:8889441

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters